Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Renal tubule water reabsorption describes the multi-segmental process in the kidney whereby water is reabsorbed from the tubular fluid in nephrons back into the peritubular capillaries to maintain body water balance. It is mediated primarily by passive osmosis in the proximal tubule and descending limb of the loop of Henle, and by regulated action of aquaporin water channels under the control of vasopressin (antidiuretic hormone, AVP) in the collecting duct. This process does not refer to a single protein but involves key molecular components including aquaporin-1 (proximal tubule, descending limb), aquaporin-2 (collecting duct principal cells, regulated by AVP), sodium transporters (Na⁺/K⁺ ATPase, NKCC2), and urea transporters (UT-A1/3)[2][4][5]. The segment-specific permeability of the renal tubule is vital, with most water reabsorbed constitutively in the proximal tubule and descending loop, but fine regulation occurring in the collecting duct in response to AVP (vasopressin)[2][3][5]. Pharmacological manipulation (e.g., with diuretics or vasopressin analogs/antagonists) targets some of these molecular players but not the abstract process itself. Therapeutically Relevant Underlying Targets and Mechanisms: While "renal tubule water reabsorption" itself is not a target: Drugs target vasopressin V2 receptor (e.g., tolvaptan, desmopressin); Drugs target or modulate aquaporin-2 and other transporters indirectly via hormonal pathways; Diuretics target sodium reabsorption (e.g., furosemide at NKCC2 transporter). Summary: "Renal tubule water reabsorption" is a physiological function, not a single molecular target, receptor, or enzyme, and should not be listed as a canonical drug target in structured drug/target databases. Specific molecular entities involved in this process include aquaporin-1, aquaporin-2, vasopressin V2 receptor, Na⁺/K⁺ ATPase, and NKCC2[2][3][4][5]. For structured databases, map to these specific molecular targets if drug interactions are the focus, not to the high-level physiological process.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Renal tubule water reabsorption.